127 related articles for article (PubMed ID: 7622436)
1. Pyripyropenes, Novel ACAT inhibitors produced by Aspergillus fumigatus. III. Structure elucidation of pyripyropenes E to L.
Tomoda H; Tabata N; Yang DJ; Takayanagi H; Nishida H; Omura S; Kaneko T
J Antibiot (Tokyo); 1995 Jun; 48(6):495-503. PubMed ID: 7622436
[TBL] [Abstract][Full Text] [Related]
2. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R.
Tomoda H; Tabata N; Yang DJ; Namatame I; Tanaka H; Omura S; Kaneko T
J Antibiot (Tokyo); 1996 Mar; 49(3):292-8. PubMed ID: 8626247
[TBL] [Abstract][Full Text] [Related]
3. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. II. Structure elucidation of pyripyropenes A, B, C and D.
Kim YK; Tomoda H; Nishida H; Sunazuka T; Obata R; Omura S
J Antibiot (Tokyo); 1994 Feb; 47(2):154-62. PubMed ID: 8150710
[TBL] [Abstract][Full Text] [Related]
4. Pyripyropenes, novel inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. I. Production, isolation, and biological properties.
Tomoda H; Kim YK; Nishida H; Masuma R; Omura S
J Antibiot (Tokyo); 1994 Feb; 47(2):148-53. PubMed ID: 8150709
[TBL] [Abstract][Full Text] [Related]
5. GERI-BP001 compounds, new inhibitors of acyl-CoA: cholesterol acyltransferase from Aspergillus fumigatus F37. I. Production, isolation, and physico-chemical and biological properties.
Jeong TS; Kim SU; Son KH; Kwon BM; Kim YK; Choi MU; Bok SH
J Antibiot (Tokyo); 1995 Aug; 48(8):751-6. PubMed ID: 7592016
[TBL] [Abstract][Full Text] [Related]
6. Pyripyropenes, highly potent inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus.
Omura S; Tomoda H; Kim YK; Nishida H
J Antibiot (Tokyo); 1993 Jul; 46(7):1168-9. PubMed ID: 8360113
[No Abstract] [Full Text] [Related]
7. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
[TBL] [Abstract][Full Text] [Related]
8. Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. III. Production, isolation and structure elucidation of new components.
Tomoda H; Tabata N; Yang DJ; Takayanagi H; Omura S
J Antibiot (Tokyo); 1995 Aug; 48(8):793-804. PubMed ID: 7592023
[TBL] [Abstract][Full Text] [Related]
9. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
[TBL] [Abstract][Full Text] [Related]
10. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
[TBL] [Abstract][Full Text] [Related]
11. Isochromophilones III-VI, inhibitors of acyl-CoA:cholesterol acyltransferase produced by Penicillium multicolor FO-3216.
Arai N; Shiomi K; Tomoda H; Tabata N; Yang DJ; Masuma R; Kawakubo T; Omura S
J Antibiot (Tokyo); 1995 Jul; 48(7):696-702. PubMed ID: 7649870
[TBL] [Abstract][Full Text] [Related]
12. Pyripyropenes, fungal sesquiterpenes conjugated with alpha-pyrone and pyridine moieties, exhibits anti-angiogenic activity against human umbilical vein endothelial cells.
Hayashi A; Arai M; Fujita M; Kobayashi M
Biol Pharm Bull; 2009 Jul; 32(7):1261-5. PubMed ID: 19571395
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of pyripyropenes fungal acyl-CoA: cholesterol acyltransferase inhibitors.
Obata R; Sunazuka T; Li Z; Tomoda H; Omura S
J Antibiot (Tokyo); 1995 Jul; 48(7):749-50. PubMed ID: 7649883
[No Abstract] [Full Text] [Related]
14. Isolation of Acyl-CoA:cholesterol acyltransferase inhibitor from Persicaria vulgaris.
Song HY; Rho MC; Lee SW; Kwon OE; Chang YD; Lee HS; Kim YK
Planta Med; 2002 Sep; 68(9):845-7. PubMed ID: 12357403
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of A-Ring Simplified Pyripyropene A Analogues as Potent and Selective Synthetic SOAT2 Inhibitors.
Ohtawa M; Arima S; Ichida N; Terayama T; Ohno H; Yamazaki T; Ohshiro T; Sato N; Omura S; Tomoda H; Nagamitsu T
ChemMedChem; 2018 Mar; 13(5):411-421. PubMed ID: 29323466
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification and structure-activity relationships of pyripyropenes. 1. Modification at the four hydroxyl groups.
Obata R; Sunazuka T; Li Z; Tian Z; Harigaya Y; Tabata N; Tomoda H; Omura S
J Antibiot (Tokyo); 1996 Nov; 49(11):1133-48. PubMed ID: 8982343
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
Ohshiro T; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
[TBL] [Abstract][Full Text] [Related]
18. GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93.
Kim YK; Lee HW; Son KH; Kwon BM; Jeong TS; Lee DH; Shin J; Seo Y; Kim SU; Bok SH
J Antibiot (Tokyo); 1996 Jan; 49(1):31-6. PubMed ID: 8609082
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
[TBL] [Abstract][Full Text] [Related]
20. Epi-cochlioquinone A, a novel acyl-CoA : cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi.
Fujioka T; Yao K; Hamano K; Hosoya T; Kagasaki T; Furukawa Y; Haruyama H; Sato S; Koga T; Tsujita Y
J Antibiot (Tokyo); 1996 May; 49(5):409-13. PubMed ID: 8682715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
